secwatch.observer — SEC 8-K summary
======================================

Issuer:     KALA BIO, Inc. (KALA)
CIK:        0001479419
Form:       8-K
Filed at:   2023-12-22T23:59:59+00:00
Accession:  0001104659-23-128542
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 5.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

KALA BIO raises ~$2.0M via private placement of Series F Convertible Preferred Stock
--------------------------------------------------------------------------------

- Gross proceeds of ~$2.0M from sale of 2,928 Series F Preferred shares at $683.00 per share.
- Each Series F Preferred share initially convertible into 100 shares of common, subject to 9.99% beneficial ownership limitation.
- Preferred stock ranks senior to common, on parity with Series E, and carries dividend rights equal to as-converted common dividends.
- Closing expected on or about December 22, 2023, subject to customary conditions and exemption under Rule 506 of Regulation D.
- Company agreed to restrictions on issuing senior/pari passu equity, incurring debt over $1M, or paying dividends without purchaser consent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1479419/000110465923128542/0001104659-23-128542-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1479419/000110465923128542/tm2333579d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-128542

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer